Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brieva

Showing results (241-250 of 376) with videos related to

Pageof 38
Sort By:
International Immunopharmacology|June 9, 2004
AM3 inhibits HBV replication through activation of peripheral blood mononuclear cellsPedro Majano, Pedro Roda-Navarro, José Luis Alonso-Lebrero, et al.
Journal of Leukocyte Biology|October 23, 2013
Syntaxin-4 is implicated in the secretion of antibodies by human plasma cellsLaura Gómez-Jaramillo, Luis Delgado-Pérez, Elena Reales, et al.
Journal of Drugs in Dermatology : JDD|September 4, 2024
INDIVIDUAL ARTICLE: Real-World Patient Cases Using Triple Lipid-Containing Cream for Cutaneous Healing Post Laser or Microneedling Radiofrequency TreatmentMichael Gold, Anneke Andriessen, Daniela Greiner-Krüger, et al.
Journal of Neuroimmunology|November 4, 2016
Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67)Mar Guasp, Nuria Solà-Valls, Eugenia Martínez-Hernández, et al.
European Journal of Immunology|May 3, 2017
Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activationRaquel de la Varga Martínez, Beatriz Rodríguez-Bayona, Gustavo A Añez, et al.
Neurology and Therapy|January 20, 2020
Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's PerspectiveJosé Meca-Lallana, Jorge Maurino, Miguel Ángel Hernández-Pérez, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
High-Dimensional Feature Selection for Automatic Classification of Coronary Stenosis Using an Evolutionary AlgorithmMiguel-Angel Gil-Rios, Ivan Cruz-Aceves, Arturo Hernandez-Aguirre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 20, 2026
Diminishing returns of disease-modifying treatment in older participants of MS clinical trialsEva Strijbis, Jop Mostert, Miguel D'Haeseleer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 22, 2022
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical TrialPatrick Vermersch, Luis Brieva-Ruiz, Robert J Fox, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2025
A Multi-Component Reaction Peptide Augmenting the Anti-Aging Benefits of Non-Ablative Laser ProcedureKun Mark Qian, Michael Kaminer, I-Chien Liao, et al.
Pageof 38

Showing results (241-250 of 376) with videos related to

Sort By:
Pageof 38
International Immunopharmacology|June 9, 2004
AM3 inhibits HBV replication through activation of peripheral blood mononuclear cellsPedro Majano, Pedro Roda-Navarro, José Luis Alonso-Lebrero, et al.
Journal of Leukocyte Biology|October 23, 2013
Syntaxin-4 is implicated in the secretion of antibodies by human plasma cellsLaura Gómez-Jaramillo, Luis Delgado-Pérez, Elena Reales, et al.
Journal of Drugs in Dermatology : JDD|September 4, 2024
INDIVIDUAL ARTICLE: Real-World Patient Cases Using Triple Lipid-Containing Cream for Cutaneous Healing Post Laser or Microneedling Radiofrequency TreatmentMichael Gold, Anneke Andriessen, Daniela Greiner-Krüger, et al.
Journal of Neuroimmunology|November 4, 2016
Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67)Mar Guasp, Nuria Solà-Valls, Eugenia Martínez-Hernández, et al.
European Journal of Immunology|May 3, 2017
Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activationRaquel de la Varga Martínez, Beatriz Rodríguez-Bayona, Gustavo A Añez, et al.
Neurology and Therapy|January 20, 2020
Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's PerspectiveJosé Meca-Lallana, Jorge Maurino, Miguel Ángel Hernández-Pérez, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
High-Dimensional Feature Selection for Automatic Classification of Coronary Stenosis Using an Evolutionary AlgorithmMiguel-Angel Gil-Rios, Ivan Cruz-Aceves, Arturo Hernandez-Aguirre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 20, 2026
Diminishing returns of disease-modifying treatment in older participants of MS clinical trialsEva Strijbis, Jop Mostert, Miguel D'Haeseleer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 22, 2022
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical TrialPatrick Vermersch, Luis Brieva-Ruiz, Robert J Fox, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2025
A Multi-Component Reaction Peptide Augmenting the Anti-Aging Benefits of Non-Ablative Laser ProcedureKun Mark Qian, Michael Kaminer, I-Chien Liao, et al.
Pageof 38